Astrana Health, Inc. (NASDAQ:ASTH) Given Average Rating of "Moderate Buy" by Brokerages

Key Points

• Astrana Health has a “Moderate Buy” consensus rating from nine analysts, with seven buys and two holds; the average 12-month price target is approximately $49.43.
• Institutional investors own 52.77% of the stock, with several major funds significantly increasing their positions or initiating new stakes.
• The company’s latest quarterly results beat earnings expectations, reporting $0.80 EPS versus $0.34 expected, while revenue rose 48.5% year over year to $972.52 million.

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nine research firms that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $49.4286.

A number of research firms have recently issued reports on ASTH. Wall Street Zen lowered shares of Astrana Health from a "buy" rating to a "hold" rating in a report on Sunday. BTIG Research lifted their price objective on shares of Astrana Health from $50.00 to $65.00 and gave the stock a "buy" rating in a research report on Tuesday, July 14th. TD Cowen boosted their target price on shares of Astrana Health from $45.00 to $50.00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. Weiss Ratings upgraded Astrana Health from a "hold (c-)" rating to a "hold (c)" rating in a report on Monday, June 1st. Finally, Needham & Company LLC raised their target price on Astrana Health from $30.00 to $41.00 and gave the stock a "buy" rating in a research report on Friday, May 8th.

Institutional Investors Weigh In On Astrana Health

Several hedge funds have recently bought and sold shares of ASTH. 325 Capital LLC lifted its position in shares of Astrana Health by 54.0% in the fourth quarter. 325 Capital LLC now owns 1,839,076 shares of the company's stock worth $45,627,000 after purchasing an additional 645,123 shares in the last quarter. Wellington Management Group LLP boosted its holdings in shares of Astrana Health by 418.3% during the fourth quarter. Wellington Management Group LLP now owns 738,853 shares of the company's stock worth $18,331,000 after purchasing an additional 596,293 shares during the period. Diamond Hill Capital Management LLC Investment Advisor purchased a new position in Astrana Health during the second quarter valued at approximately $22,088,000. Ameriprise Financial Inc. grew its position in Astrana Health by 231.0% during the third quarter. Ameriprise Financial Inc. now owns 442,314 shares of the company's stock valued at $12,540,000 after purchasing an additional 308,665 shares in the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in Astrana Health during the second quarter valued at approximately $10,902,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Price Performance

NASDAQ ASTH opened at $39.16 on Wednesday. The stock's 50-day moving average price is $41.39 and its two-hundred day moving average price is $33.12. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 1.05. The company has a market cap of $2.18 billion, a PE ratio of 47.76 and a beta of 0.87. Astrana Health has a 1 year low of $18.08 and a 1 year high of $51.60.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.80 EPS for the quarter, beating analysts' consensus estimates of $0.34 by $0.46. Astrana Health had a net margin of 1.05% and a return on equity of 10.30%. The company had revenue of $972.52 million during the quarter, compared to analyst estimates of $985.62 million. During the same period in the prior year, the firm earned $0.19 earnings per share. The business's quarterly revenue was up 48.5% on a year-over-year basis. On average, analysts predict that Astrana Health will post 1.31 EPS for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source